title: [Model approach for evaluation and treatment of men with premature ejaculation].
abstract: BACKGROUND
  Premature ejaculation (PE) is one of the most common sexual dysfunctions among men. PE is poorly defined and inadequately characterized, therefore, professionals find it difficult to cope with the diagnosis, treatment and research. Men who complain about their PE also describe their problem in different ways.
  
  
  OBJECTIVE
  This article describes the prevalence of PE, presents the different definitions of the problem and provides a model for evaluation and treatment combining medical and psychosexual techniques.
  
  
  METHODS
  The proposed model for the diagnosis and treatment of PE was composed by combining information from relevant literature with the multi-professional staff experience in our Sexual Medicine Center.
  
  
  RESULTS
  Selective serotonin release inhibitors (SSRIs) have been the most promising medication for treatment of PE. Psychosexual therapy, offering cognitive-behavioral techniques contribute to the man's ability to improve his sexual and couple relationships.
  
  
  CONCLUSIONS
  Diagnosis of PE is mainly based on sexual history as described by the male patient. Therefore, it is essential to have a comprehensive medical and sexual history, description of the effect of PE on sexual activity, and the degree of personal and couple distress. It is important to clarify the onset of the problem, as PE may be the result of another sexual dysfunction of the man or his sexual partner.
authors.affiliation: Department of Rehabilitation, Galil-Maaravi Hospital, Nahariya.
authors.forename: Arkadi
authors.initials: A
authors.lastname: Galin
authors.forename: Gila
authors.initials: G
authors.lastname: Bronner
authors.forename: Gil
authors.initials: G
authors.lastname: Raviv
mesh_terms: D000223:Adaptation, Psychological; D015928:Cognitive Behavioral Therapy; D004542:Ejaculation / Q000502:physiology*; D006801:Humans; D008297:Male; D008487:Medical History Taking; D008960:Models, Psychological; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D013315:Stress, Psychological
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors